Skip to menu Skip to content Skip to footer

2024

Conference Publication

Spatial dynamics and cellular architecture mapping in head and neck cancer: insights into immunotherapy response

Kulasinghe, Arutha (2024). Spatial dynamics and cellular architecture mapping in head and neck cancer: insights into immunotherapy response. SITC 39th Annual Meeting (SITC 2024), Houston, TX United States, 6-10 November 2024. London, United Kingdom: BMJ Group. doi: 10.1136/jitc-2024-sitc2024.0110

Spatial dynamics and cellular architecture mapping in head and neck cancer: insights into immunotherapy response

2024

Conference Publication

Multi-omic spatial data integration resolves immunometabolic heterogeneity associated with Nivolumab response in non-small cell lung cancer (NSCLC) patients

Yan, Raymond, Quinn, Shannon, Falkenstein, Brian, Monkman, James, O’Bryne, Kenneth, Chakra Chennubhotla, S, Pullara, Filippo and Kulasinghe, Arutha (2024). Multi-omic spatial data integration resolves immunometabolic heterogeneity associated with Nivolumab response in non-small cell lung cancer (NSCLC) patients. SITC 39th Annual Meeting (SITC 2024), Houston, TX United States, 6-10 November 2024. London, United Kingdom: BMJ Group. doi: 10.1136/jitc-2024-sitc2024.0212

Multi-omic spatial data integration resolves immunometabolic heterogeneity associated with Nivolumab response in non-small cell lung cancer (NSCLC) patients

2024

Conference Publication

An integrated approach to high dimensional spatial proteomics and interaction mapping in head and neck cancer tissues prior to immune checkpoint inhibitor therapy

Naei, Vahid Yaghoubi, Monkman, James, Hughes, Brett and Kulasinghe, Arutha (2024). An integrated approach to high dimensional spatial proteomics and interaction mapping in head and neck cancer tissues prior to immune checkpoint inhibitor therapy. SITC 39th Annual Meeting (SITC 2024), Houston, TX United States, 6-10 November 2024. London, United Kingdom: BMJ Group. doi: 10.1136/jitc-2024-sitc2024.0558

An integrated approach to high dimensional spatial proteomics and interaction mapping in head and neck cancer tissues prior to immune checkpoint inhibitor therapy

2024

Conference Publication

Development of a novel immuno-metabolic spatial signature to predict response and resistance to immunotherapy in NSCLC patients

Markovits, Ettai, Monkman, James, Aung, Thazin, Reeves, Jason, O’Byrne, Ken, Czertock, Rotem, Puig, Oscar, Rimm, David and Kulasinghe, Arutha (2024). Development of a novel immuno-metabolic spatial signature to predict response and resistance to immunotherapy in NSCLC patients. SITC 39th Annual Meeting (SITC 2024), Houston, TX United States, 6-10 November 2024. London, United Kingdom: BMJ Group. doi: 10.1136/jitc-2024-sitc2024.0109

Development of a novel immuno-metabolic spatial signature to predict response and resistance to immunotherapy in NSCLC patients

2024

Conference Publication

Characterization of Circulating Tumor-Associated and Immune Cells in Advanced-Stage NSCLC

Yaghoubi Naei, V., Mullally, W., Warkiani, M., O'Byrne, K. and Kulasinghe, A. (2024). Characterization of Circulating Tumor-Associated and Immune Cells in Advanced-Stage NSCLC. 2024 World Conference on Lung Cancer, San Diego, CA United States, 7-10 September 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.jtho.2024.09.473

Characterization of Circulating Tumor-Associated and Immune Cells in Advanced-Stage NSCLC

2024

Conference Publication

Deciphering Single-Cell Resolved Tumour Microenvironment Profiles Using Spatial Metabolic Mapping

Kulasinghe, A., Monkman, J., Markovits, E. and O'Byrne, K. (2024). Deciphering Single-Cell Resolved Tumour Microenvironment Profiles Using Spatial Metabolic Mapping. 2024 World Conference on Lung Cancer, San Diego, CA United States, 7-10 September 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.jtho.2024.09.032

Deciphering Single-Cell Resolved Tumour Microenvironment Profiles Using Spatial Metabolic Mapping

2024

Conference Publication

Multiomic spatial profiling of whole-slide NSCLC tissues from patients receiving anti PD-1 therapy identifies metabolic phenotypes associated with therapy resistance

Kulasinghe, A., Monkman, J. and O'Byrne, K.J. (2024). Multiomic spatial profiling of whole-slide NSCLC tissues from patients receiving anti PD-1 therapy identifies metabolic phenotypes associated with therapy resistance. ESMO Congress 2024, Barcelona, Spain, 13-17 September 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2024.08.2037

Multiomic spatial profiling of whole-slide NSCLC tissues from patients receiving anti PD-1 therapy identifies metabolic phenotypes associated with therapy resistance

2024

Conference Publication

Unraveling functionally distinct metabolic programs to predict immunotherapy response in non-small cell lung cancer (NSCLC)

Kulasinghe, A., Yan, R., Quinn, S., Falkenstein, B., Monkman, J., O'Byrne, K.J., Chennubhotla, S.C. and Pullara, F. (2024). Unraveling functionally distinct metabolic programs to predict immunotherapy response in non-small cell lung cancer (NSCLC). ESMO Congress 2024, Barcelona, Spain, 13-17 September 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2024.08.142

Unraveling functionally distinct metabolic programs to predict immunotherapy response in non-small cell lung cancer (NSCLC)

2024

Conference Publication

Spatially resolved cell profiling unveils tumor metabolic states associated with immunotherapy response in NSCLC

Monkman, James, Czertok, Rotem, Bookstein, Shai, Arbiv, Becky, Shachaf, Yuval, Elran, Ron, Bloom, Kenneth, Puig, Oscar, O'Byrne, Ken, Markovits, Ettai and Kulasinghe, Arutha (2024). Spatially resolved cell profiling unveils tumor metabolic states associated with immunotherapy response in NSCLC. American Association for Cancer Research Annual Meeting 2024, San Diego, CA United States, 5-10 April 2024. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2024-1158

Spatially resolved cell profiling unveils tumor metabolic states associated with immunotherapy response in NSCLC

2024

Conference Publication

Integration of high-plex tumor-Immune phenotyping and checkpoint interactions for deeper spatial characterization of human cancer tissues

Bodbin, Sara, Ma, Ning, Pratapa, Aditya, Nikulina, Nadya, Monkman, James, Jhaveri, Niyati, Elofsson, Hampus, Basu, Subham, Zieba-Wicher, Agata and Kulasinghe, Arutha (2024). Integration of high-plex tumor-Immune phenotyping and checkpoint interactions for deeper spatial characterization of human cancer tissues. American Association for Cancer Research Annual Meeting 2024, San Diego, CA United States, 5-10 April 2024. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2024-1525

Integration of high-plex tumor-Immune phenotyping and checkpoint interactions for deeper spatial characterization of human cancer tissues

2024

Conference Publication

Spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma revealed immune cell type infiltration into the TME as a predictor of immunotherapy response

Sadeghirad, Habib, Tan, Chin Wee, Liu, Ning, Monkman, James, Cooper, Caroline, O’Byrne, Ken, Davis, Melissa, Hughes, Brett and Kulasinghe, Arutha (2024). Spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma revealed immune cell type infiltration into the TME as a predictor of immunotherapy response. American Association for Cancer Research Annual Meeting 2024, San Diego, CA United States, 5-10 April 2024. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2024-1154

Spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma revealed immune cell type infiltration into the TME as a predictor of immunotherapy response

2024

Conference Publication

Ultrahigh-plex spatial phenotyping of head and neck cancer tissue uncovers multiomic signatures of immunotherapy response

Pratapa, Aditya, Hernandez, Lydia, Cheikh, Bassem Ben, Jhaveri, Niyati and Kulasinghe, Arutha (2024). Ultrahigh-plex spatial phenotyping of head and neck cancer tissue uncovers multiomic signatures of immunotherapy response. American Association for Cancer Research Annual Meeting 2024, San Diego, CA United States, 5-10 April 2024. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2024-5503

Ultrahigh-plex spatial phenotyping of head and neck cancer tissue uncovers multiomic signatures of immunotherapy response

2024

Conference Publication

Spatial profiling of pediatric rhabdomyosarcoma to elucidate their immunosuppressive tumor microenvironment

Tu, Cui, Tan, Chin Wee, Liu, Ning, Kulasinghe, Arutha and Souza-Fonseca-Guimaraes, Fernando (2024). Spatial profiling of pediatric rhabdomyosarcoma to elucidate their immunosuppressive tumor microenvironment. American Association for Cancer Research Annual Meeting 2024, San Diego, CA United States, 5-10 April 2024. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2024-73

Spatial profiling of pediatric rhabdomyosarcoma to elucidate their immunosuppressive tumor microenvironment

2024

Conference Publication

Defining PD-1/PD-L1 receptor-ligand interactions in the head and neck cancer tumor microenvironment identifies unique ‘immune cell rivers’ of cellular interactions

Sadeghirad, Habib, Naei, Vahid Yaghoubi, Monkman, James, Basu, Subham, Wicher, Agata, Ladwa, Rahul, Hughes, Brett G.M. and Kulasinghe, Arutha (2024). Defining PD-1/PD-L1 receptor-ligand interactions in the head and neck cancer tumor microenvironment identifies unique ‘immune cell rivers’ of cellular interactions. American Association for Cancer Research Annual Meeting 2024, San Diego, CA United States, 5-10 April 2024. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2024-5188

Defining PD-1/PD-L1 receptor-ligand interactions in the head and neck cancer tumor microenvironment identifies unique ‘immune cell rivers’ of cellular interactions

2024

Conference Publication

A spatio-temporal approach to mapping the dynamics of cutaneous squamous cell carcinoma progression and immunotherapy response: A journey through TiME

Jhaveri, Niyati, Ben Cheikh, Bassem, Klymyshyn, Dmytro, Ma, Ning, Pratapa, Aditya, Monkman, James, Nelson, Nadine and Kulasinghe, Arutha (2024). A spatio-temporal approach to mapping the dynamics of cutaneous squamous cell carcinoma progression and immunotherapy response: A journey through TiME. American Association for Cancer Research Annual Meeting 2024, San Diego, CA United States, 5-10 April 2024. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2024-6872

A spatio-temporal approach to mapping the dynamics of cutaneous squamous cell carcinoma progression and immunotherapy response: A journey through TiME

2024

Conference Publication

Spatial-specific gene signatures to predict immunotherapy outcomes in lung cancer

Aung, Thazin N., Moutafi, Myrto, Trontzas, Ioannis, Kulasinghe, Arutha, Monkman, James, Gavrielatou, Niki, Vathiotis, Ioannis, Warrell, Jonathan H. and Rimm, David L. (2024). Spatial-specific gene signatures to predict immunotherapy outcomes in lung cancer. American Association for Cancer Research Annual Meeting 2024, San Diego, CA United States, 5-10 April 2024. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2024-1141

Spatial-specific gene signatures to predict immunotherapy outcomes in lung cancer

2023

Conference Publication

Extracellular Small Vesicle Phosphorylated PD-L1 Liquid Biopsy Levels Correlate with Tumour Proportion Score (TPS) in NSCLC

O'Byrne, K., Shanmugasundaram, K.B., Ahmed, E., Kulasinghe, A., Monkman, J., Fletcher, J.A., Mainwaring, P.N., Masud, M.K., Park, H., Hossain, M.S.A., Yamauchi, Y., Sina, A.A.I., Wuethrich, A. and Trau, M. (2023). Extracellular Small Vesicle Phosphorylated PD-L1 Liquid Biopsy Levels Correlate with Tumour Proportion Score (TPS) in NSCLC. 2023 World Conference on Lung Cancer, Singapore, 9-12 September 2023. New York, NY United States: Elsevier. doi: 10.1016/j.jtho.2023.09.432

Extracellular Small Vesicle Phosphorylated PD-L1 Liquid Biopsy Levels Correlate with Tumour Proportion Score (TPS) in NSCLC

2023

Conference Publication

High-dimensional profiling of the tumour microenvironment of non-small cell lung cancer

Kulasinghe, A., Monkman, J., Moradi, A., Yunis, J., Ivison, G., Mayer, A. and O'Byrne, K. (2023). High-dimensional profiling of the tumour microenvironment of non-small cell lung cancer. 2023 World Conference on Lung Cancer, Singapore, Singapore, 9 - 12 September 2023. New York, NY, United States: Elsevier.

High-dimensional profiling of the tumour microenvironment of non-small cell lung cancer

2023

Conference Publication

From pixels to clinical Insights: deciphering spatial tumour-immune microenvironment features of immunotherapy response and resistance in lung cancer

Kulasinghe, Arutha (2023). From pixels to clinical Insights: deciphering spatial tumour-immune microenvironment features of immunotherapy response and resistance in lung cancer. Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting, San Diego, CA United States, 1-5 November 2023. London, United Kingdom: BMJ Group. doi: 10.1136/jitc-2023-sitc2023.0099

From pixels to clinical Insights: deciphering spatial tumour-immune microenvironment features of immunotherapy response and resistance in lung cancer

2023

Conference Publication

Identifying a role for macrophages in predicting immunotherapy responses of non-small cell lung cancer (NSCLC)

Ma, Ning, Pratapa, Aditya, Monkman, James, O’Byrne, Ken and Kulasinghe, Arutha (2023). Identifying a role for macrophages in predicting immunotherapy responses of non-small cell lung cancer (NSCLC). Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting, San Diego, CA United States, 1-5 November 2023. London, United Kingdom: BMJ Group. doi: 10.1136/jitc-2023-sitc2023.0105

Identifying a role for macrophages in predicting immunotherapy responses of non-small cell lung cancer (NSCLC)